Acadia Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023

Rhea-AI Summary

Acadia Pharmaceuticals will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 9:00 a.m. PT. The presentation will include a live Q&A session and can be accessed via their website under the investors section. An archived recording will be available for one month post-event. Acadia has over 25 years in healthcare, focusing on breakthroughs in neuroscience, including therapies for Parkinson's disease psychosis and ongoing clinical developments for schizophrenia and Rett syndrome.

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 41^st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 9:00 a.m. Pacific Time, followed by a question and answer session.

A live webcast of Acadia’s presentation will be accessible on the company’s website, www.acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Rett syndrome and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221221005543/en/

Media Contact:

Acadia Pharmaceuticals Inc.

Deb Kazenelson

(818) 395-3043

media@acadia-pharm.com

Investor Contact:

Acadia Pharmaceuticals Inc.

Mark Johnson, CFA

(858) 261-2771

ir@acadia-pharm.com

 

Source: Acadia Pharmaceuticals Inc.

FAQ

What will Acadia Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Acadia Pharmaceuticals will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, discussing their advancements in neuroscience.

When is Acadia Pharmaceuticals' presentation at the J.P. Morgan Conference?

Acadia Pharmaceuticals' presentation is scheduled for January 10, 2023, at 9:00 a.m. Pacific Time.

How can I watch Acadia Pharmaceuticals' presentation live?

The live presentation by Acadia Pharmaceuticals will be available on their website under the investors section.

Will there be a replay of Acadia Pharmaceuticals' presentation?

Yes, an archived recording of the presentation will be accessible on Acadia's website for approximately one month after the event.

What therapies has Acadia Pharmaceuticals developed?

Acadia Pharmaceuticals has developed therapies for hallucinations and delusions associated with Parkinson's disease psychosis and is focusing on treatments for schizophrenia and Rett syndrome.